Full Professor of Coimbra University; Portugal Vice-Rector of University of Coimbra (Research): 2011 Dean of Faculty of Pharmacy (2010-2011). CNC (Centre for Neuroscience and Cell Biology - Coimbra University) Leader Group of Pharmacometrics. Member of CAM (INFARMED); CAM – Medicines Evaluation Committee; INFARMED – Portuguese Regulatory Agency. Referee for more than twenty journals, including the Evidence-based Complementary and Alternative Medicine. Awards: •Portuguese Pharmaceutical Society Award 1989; •Portuguese Pharmacists College Award 1991; •Portuguese Pediatrics Society Award 1997; •Portuguese Epilepsy Association Award 2000; •Portuguese Epilepsy Association Award 2001; •Portuguese Epilepsy Association Award 2002; •Eminent Scientist of the Year 2006 (Clinical Pharmacology) [International Research Promotion Council (IRPC)]; •“Top-50 most cited articles" - Journal of Chromatography B (from 2002 to 2007) [Elsevier]; •"Pharmacist of the Year - 2008" [Portuguese award]; •Portuguese Epilepsy Association Award 2012. Involved in more than 80 nonclinical and clinical trials (phase I, II & III) of several New Chemical Entities (NCEs). Responsible for biostatistical and pharmacokinetic/pharmacodynamic data analysis; co-responsible for Clinical Trial Protocols (CTPs), Clinical Trial Reports (CTRs), and member of Steering Committees for Phase III studies. Deeply involved in the development of the first Portuguese Medicine (Eslicarbazepine Acetate [Zebinix®; Exalief®]; Laboratories BIAL - Portugal) that reach the market in 2010. Deeply involved in the development of the first Portuguese Radiopharmaceutical (Fluodesoxiglucose [18F] UC [FDG?UC]; ICNAS Production - University of Coimbra; Portugal) that reach the market in 2012. Experience in EMA and FDA meetings during the drug development process of several NCEs. Author or co-author in more than 300 oral and poster communications & more than 150 publications.
Biography Updated on 18 October 2012